CD19 and neoplasm: The aim of the present study was to further investigate the motility and tissue invasion behaviour of non‐virally engineered CD19‐CAR‐NK cells compared to non‐transduced (NT) NK cells in microchannels as well as within patient‐derived hyperplastic lymphatic and DLBCL tumour tissues.